Benitec Biopharma Inc. (BNTC) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$23.59M | -21.6% |
| 2024 | -$19.40M | -7.7% |
| 2023 | -$18.01M | -13.3% |
| 2022 | -$15.90M | -23.9% |
| 2021 | -$12.83M | -70.3% |
| 2020 | -$7.54M | -257.3% |
| 2019 | $4.79M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$23.59M | -21.6% |
| 2024 | -$19.40M | -7.7% |
| 2023 | -$18.01M | -13.3% |
| 2022 | -$15.90M | -23.9% |
| 2021 | -$12.83M | -70.3% |
| 2020 | -$7.54M | -257.3% |
| 2019 | $4.79M | — |